Australia markets closed

Starpharma Holdings Limited (SPL.XA)

Cboe AU - Cboe AU Real-time price. Currency in AUD
Add to watchlist
0.1275+0.0025 (+2.00%)
At close: 03:59PM AEST
Currency in AUD

Valuation measures4

Market cap (intra-day) N/A
Enterprise value N/A
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)N/A
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 0.77
52-week change 3-75.00%
S&P500 52-week change 321.23%
52-week high 30.5250
52-week low 30.1050
50-day moving average 30.1328
200-day moving average 30.1720

Share statistics

Avg vol (3-month) 3115.58k
Avg vol (10-day) 3164.16k
Shares outstanding 5N/A
Implied shares outstanding 6N/A
Float 8383.12M
% held by insiders 17.38%
% held by institutions 139.61%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 4N/A
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 June 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin -79.79%
Operating margin (ttm)-12.88%

Management effectiveness

Return on assets (ttm)-10.50%
Return on equity (ttm)-22.25%

Income statement

Revenue (ttm)10.52M
Revenue per share (ttm)0.03
Quarterly revenue growth (yoy)369.00%
Gross profit (ttm)N/A
EBITDA -8.18M
Net income avi to common (ttm)-8.39M
Diluted EPS (ttm)-0.0440
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)32.13M
Total cash per share (mrq)0.08
Total debt (mrq)3.13M
Total debt/equity (mrq)9.08%
Current ratio (mrq)5.60
Book value per share (mrq)0.08

Cash flow statement

Operating cash flow (ttm)-6.36M
Levered free cash flow (ttm)-3.85M